Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Niaprazine Trihydrochloride
2. Nopron
1. 27367-90-4
2. Nopron
3. 1709 Cerm
4. Niaprazine, (+)-
5. Niaprazine, (-)-
6. 1709cerm; Nopron
7. R2h3yn6e3l
8. N-(4-(4-(4-fluorophenyl)piperazin-1-yl)butan-2-yl)nicotinamide
9. 1709cerm
10. 5qkw305n9f
11. 1709-cerm
12. Niaprazine (inn)
13. N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-3-pyridinecarboxamide
14. N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide
15. J10.716f
16. Niaprazine [inn]
17. 1346q758l9
18. Nicotinamide, N-(3-(4-(p-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-
19. 3-pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-
20. Niaprazina
21. Niaprazinum
22. Niaprazine [inn:dcf]
23. Niaprazinum [inn-latin]
24. Niaprazina [inn-spanish]
25. 3-pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-, (+)-
26. 3-pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-, (-)-
27. 119306-37-5
28. 119328-74-4
29. Einecs 248-431-5
30. Unii-r2h3yn6e3l
31. Brn 0844157
32. N-{4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl}pyridine-3-carboxamide
33. Nopron (tn)
34. Niaprazine [mi]
35. N-(3-(4-(p-fluorophenyl)-1-piperazinyl)-1-methylpropyl)nicotinamide
36. Niaprazine [mart.]
37. Niaprazine [who-dd]
38. Unii-5qkw305n9f
39. Schembl352977
40. Chembl2105141
41. Dtxsid10865369
42. Chebi:135505
43. Unii-1346q758l9
44. Db13687
45. Ac-36434
46. Bs-49185
47. Hy-105542
48. Cs-0026220
49. Ft-0687290
50. D07333
51. E75895
52. Q631457
| Molecular Weight | 356.4 g/mol |
|---|---|
| Molecular Formula | C20H25FN4O |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 356.20123960 g/mol |
| Monoisotopic Mass | 356.20123960 g/mol |
| Topological Polar Surface Area | 48.5 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 434 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N05 - Psycholeptics
N05C - Hypnotics and sedatives
N05CM - Other hypnotics and sedatives
N05CM16 - Niaprazine
Global Sales Information
ABOUT THIS PAGE
14
PharmaCompass offers a list of Niaprazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Niaprazine manufacturer or Niaprazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Niaprazine manufacturer or Niaprazine supplier.
PharmaCompass also assists you with knowing the Niaprazine API Price utilized in the formulation of products. Niaprazine API Price is not always fixed or binding as the Niaprazine Price is obtained through a variety of data sources. The Niaprazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Niaprazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Niaprazine, including repackagers and relabelers. The FDA regulates Niaprazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Niaprazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Niaprazine supplier is an individual or a company that provides Niaprazine active pharmaceutical ingredient (API) or Niaprazine finished formulations upon request. The Niaprazine suppliers may include Niaprazine API manufacturers, exporters, distributors and traders.
Niaprazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Niaprazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Niaprazine GMP manufacturer or Niaprazine GMP API supplier for your needs.
A Niaprazine CoA (Certificate of Analysis) is a formal document that attests to Niaprazine's compliance with Niaprazine specifications and serves as a tool for batch-level quality control.
Niaprazine CoA mostly includes findings from lab analyses of a specific batch. For each Niaprazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Niaprazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Niaprazine EP), Niaprazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Niaprazine USP).
